FDA approves Merck drug to reverse effects of muscle relaxants
December 15, 2015 at 16:01 PM EST
Dec 15 (Reuters) - Merck & Co Inc.'s drug to reverse the effects of muscle relaxants used during surgery has won U.S. approval.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.